Prelude Therapeutics to Present Preclinical Cancer Research at AACR Annual Meeting 2024
WILMINGTON, DE — Delaware-based biopharmaceutical company, Prelude Therapeutics Incorporated, is set to present preclinical data on three of its innovative cancer drug candidates at the American Association for Cancer Research …
Prelude Therapeutics to Present Preclinical Cancer Research at AACR Annual Meeting 2024 Read More